PBM vs REGN: Which Stock is Better?
Side-by-side comparison of Psyence Biomedical Ltd. Common Shares and Regeneron Pharmaceuticals Inc in 2026
PBM
Psyence Biomedical Ltd. Common Shares
—
REGN
Regeneron Pharmaceuticals Inc
$632.90
Key Metrics Comparison
| Metric | PBM | REGN | Winner |
|---|---|---|---|
| Market Cap | $3.11M | $59.10B | REGN |
| P/E Ratio | 0.13 | 13.91 | PBM |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze PBM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBM or REGN a better investment?
Comparing PBM and REGN: Psyence Biomedical Ltd. Common Shares has a market cap of $3.11M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBM and REGN?
PBM (Psyence Biomedical Ltd. Common Shares) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBM or REGN?
Based on P/E ratios, PBM trades at a lower multiple (0.1x vs 13.9x).
Which is growing faster: PBM or REGN?
Both PBM and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: PBM or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: PBM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $3.11M for PBM.
Should I buy PBM or REGN in 2026?
Both PBM and REGN have investment merit. PBM trades at $N/A while REGN trades at $632.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBM and REGN stock?
Key differences: Market Cap ($3.11M vs $59.10B), P/E Ratio (0.1x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy PBM or REGN in 2026?
The choice between PBM and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between PBM and REGN?
PBM (Psyence Biomedical Ltd. Common Shares) has a market cap of $3.11M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.